Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation (PRCT)
NasdaqGM: PRCT
· 实时价格 · USD
21.85
+0.94 (4.50%)
收盘价： Sep 04, 2026, 8:00 PM
22.89
+0.57%
盘后: 7:56 PM
股价、关键数字和最新消息，都在这一页。
PROCEPT BioRobotics Corporation（PRCT）股价、分析与数据
暂无数据
| 买价 | 13.9 |
| 市值 | 1.3B |
| 营收（TTM） | 337M |
| 净利润（TTM） | -110M |
| 0.90 | |
| -1.95 | |
| n/a | |
| -19.74 | |
| 市净率（TTM） | 3.83 |
| 市销率（TTM） | 3.86 |
| 财报日期 | Nov 4, 2026 |
| 卖价 | 22.04 |
| 成交量 | 345,314 |
| 20日均量 | 1,578,080 |
| 开盘价 | 20.86 |
| 前收盘价 | 20.91 |
| 日内区间 | 20.80 - 22.00 |
| 52周区间 | 16.66 - 41.51 |
| 分析师 | 持有 |
| 目标价 | 21 (-3.89%) |
| 分红 | n/a |
| 除息日 | n/a |
关于 PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided rob...
公司完整简介财报意外
PROCEPT BioRobotics 已于 Aug 4, 2026 发布季度财报：
- 营收为 $94.5M 低于预期 $0, ， 19.34% 同比增长.
- 每股收益为 -0.47 低于预期 -0.02, ， -34.29% 同比下滑.
第 1 页，共 2 页